Abstract
Immunization of animals with acetylcholine receptor (AChR) protein from the electric organs of Electrophorus electricus and Torpedo californica induces an autoimmune response to the AChR of mammalian skeletal muscle. Rats and guinea pigs develop experimental autoimmune myasthenia gravis (EAMG) after a single inoculation with small quantities of AChR and adjuvant. The indicence and severity of disease appears to depend on the dose of AChR and stability of the emulsion. EAMG is strikingly similar to myasthenia gravis (MG) of man in its clinical picture and its electrophysiological abnormalities. The presence of antibodies to syngeneic rat muscle AChR in the serum of rats with EAMG documents the existence of autoimmunity in the experimental disease. A common immunopathogenesis is suggested for both EAMG and mg.
Full Text
The Full Text of this article is available as a PDF (725.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chang C. C., Lee C. Y. Electrophysiological study of neuromuscular blocking action of cobra neurotoxin. Br J Pharmacol Chemother. 1966 Nov;28(2):172–181. doi: 10.1111/j.1476-5381.1966.tb01883.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fambrough D. M., Drachman D. B., Satyamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science. 1973 Oct 19;182(4109):293–295. doi: 10.1126/science.182.4109.293. [DOI] [PubMed] [Google Scholar]
- Fraser D. C., Palmer A. C., Senior J. E., Parkes J. D., Yealland M. F. Myasthenia gravis in the dog. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):431–437. doi: 10.1136/jnnp.33.4.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karlsson E., Arnberg H., Eaker D. Isolation of the principal neurotoxins of two Naja naja subspecies. Eur J Biochem. 1971 Jul 15;21(1):1–16. doi: 10.1111/j.1432-1033.1971.tb01433.x. [DOI] [PubMed] [Google Scholar]
- Lambert E. H., Elmqvist D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann N Y Acad Sci. 1971 Sep 15;183:183–199. doi: 10.1111/j.1749-6632.1971.tb30750.x. [DOI] [PubMed] [Google Scholar]
- Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet. 1971 Mar 27;1(7700):630–633. doi: 10.1016/s0140-6736(71)91557-1. [DOI] [PubMed] [Google Scholar]
- NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
- Ozdemir C., Young R. R. Electrical testing in myasthenia gravis. Ann N Y Acad Sci. 1971 Sep 15;183:287–302. doi: 10.1111/j.1749-6632.1971.tb30759.x. [DOI] [PubMed] [Google Scholar]
- Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 1973 May 25;180(4088):871–872. doi: 10.1126/science.180.4088.871. [DOI] [PubMed] [Google Scholar]
- Patrick J., Lindstrom J., Culp B., McMillan J. Studies on purified eel acetylcholine receptor and anti-acetylcholine receptor antibody. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3334–3338. doi: 10.1073/pnas.70.12.3334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seybold M. E., Drachman D. B. Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med. 1974 Jan 10;290(2):81–84. doi: 10.1056/NEJM197401102900204. [DOI] [PubMed] [Google Scholar]
- Seybold M. E., Howard F. M., Jr, Duane D. D., Payne W. S., Harrison E. G., Jr Thymectomy in juvenile myasthenia gravis. Arch Neurol. 1971 Nov;25(5):385–392. doi: 10.1001/archneur.1971.00490050019001. [DOI] [PubMed] [Google Scholar]
- VAN DER GELD H., FELTKAMP T. E., VAN LOGHEM J., OOSTERHUIS H. J., BIEMOND A. MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS. Lancet. 1963 Aug 24;2(7304):373–375. doi: 10.1016/s0140-6736(63)93055-1. [DOI] [PubMed] [Google Scholar]